Skip to main content

Archive

OHFT Researchers, staff and partners meet the Cowley community

Recently researchers, staff and colleagues from across Oxfordshire research held an informal drop in engagement session for women and children in Cowley.


New shingles vaccine could reduce risk of dementia – major study indicates

The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine.


Recruitment open for healthy participants in the OxSENSE study

University of Oxford and Oxford Health Biomedical Research Centre (OH BRC) supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of semaglutide on cognition and energy in healthy volunteers.


New Therapeutic Approaches in Translational Mental Health

Academia Meets Industry – Grand Challenges and New Horizons

Monday 16 September 2024, Mathematical Institute, Oxford


Open Day at Westgate Centre showcases Oxford’s groundbreaking research

Recently, visitors to Oxford’s Westgate Centre were able to learn about the world-class healthcare research taking place in the city.


Oxford Health researcher contributes to article on new treatments for depression

Dr Frederico Magalhaes, Consultant Child and Adolescent Psychiatrist at Oxford Health’s Child and Adolescent Mental Health Service (CAMHS) has contributed to a recent article published in the BMJ.


Oxford Health Clinical Research Facility and OHFT Research Delivery Teams join Oxford Pride 2024 celebrations

Research staff at Oxford Health’s Clinical Research Facility (CRF) and the Research Delivery Teams from Oxford Health NHS Foundation Trust ran a joint stall at Oxford Pride to show support for the LGBTQIA+ community and seek feedback from attendees on their awareness of mental health research.


Enhancing home care through infection diagnostics research

Recently, Oxford Academic Health Partners (OAHP) spoke with Specialist Practitioner Kirsty Bartlett about her research into how diagnostic tools could be used by practitioners in home settings to reduce the overprescribing of antibiotics for non-bacterial infections.


Oxford Health NHS Foundation Trust recognised as top recruiting site for revolutionary Psychosis study

The Prevalence in Pathogenic Antibodies in Psychosis (PPIP2) study looks at the presence of certain antibodies in the blood of individuals with psychosis. It is understood that these specific antibodies may be created mistakenly by the immune system in response to an “attack”.


Oxford Health NHS Foundation Trust Director of Research and Development appointed as University of Oxford Associate Professor

OHFT Director of Research and Development, Prof. Vanessa Raymont has been conferred the title Associate Professor by the University of Oxford’s Medical Sciences Division.